Indian companies leave footprints on Russian generic drug market
07 October 2013
Ranbaxy, India’s largest generic drug manufacturer announced the completion of 20 years in Russia. It is among many Indian players struggling against tough competition from European and domestic drug manufacturers in Russian emerging generic drugs market.
ROSNANO will allocate additional financing to “Russian Membranes”
04 October 2013
The board of directors at the meeting in absentia has taken decision about changing the main parameters of ROSNANO participation in the investment project “Russian Membranes: modern production establishment of nano-structural membranes and separation modules on its basis”.
Dmitry Medvedev: Development of “Skolkovo” will be continued
04 October 2013
In the article, named as “Time of simple solutions has gove”, the Head of Government says about reset of import taxes for scientific equipment and materials, and calls large Russian companies to invest money in science more actively, and Government – find opportunities to stimulate such investments.
The portfolio Company of ROSNANO “BIND Therapeutics” has conducted IPO at NAS
01 October 2013
BIND Therapeutics, Inc., the portfolio company of ROSNANO, has finished the IPO of 4.700.000 common shares. Cost of IPO comprised $15.00 per one share. In the result of BIND Therapeutics’s IPO, there has been attracted $70.5M (before the discount and underwriters’ commission deduction).
26 September 2013
With Russia pegged as one of the world's fastest-growing markets, drug makers have been angling to build up their businesses here. For free access to the market, the Russian government now requires foreign companies to team up with local players – and to share technology with them.
Pharma packaging growing market with openings for good ideas
26 September 2013
Market expected to grow at 5.6% annually through 2018.
Advance Pharmaceutical to invest $25 million in building plant in Russia
18 September 2013
USA-based privately-held drugmaker Advance Pharmaceutical Inc is considering establishing a facility for the production of its drugs in Russia’s Belgorod region (Central Russia), according to the company. Advance Pharmaceutical engages in the design, research and development, manufacture, marketing and distribution of prescription and over the counter pharmaceutical products.
Russia Decides Pre-2013 Device Clinical Trials Can Support Marketing Approval
18 September 2013
Russia’s Federal Service on Healthcare Surveillance (Roszdravnadzor) and the Ministry of Health have agreed that clinical trials conducted on medical devices prior to January 2013 can be used to support applications for the renewal of or new marketing registration for devices in the 2013-2014 timeframe.
In Moscow, microbiologists try to strip germs of defensive power
16 September 2013
In a momentous fundamental science discovery, Russian researchers now appear to know ways of improving antibiotics-based therapies. And not only therapies, as scientists of Moscow’s Vinogradsky Institute of Microbiology said as early as last year. In a broader implication, the research results may also help domestic and global industry prevent corrosion of pipes and equipment.
Russian scientists working on anti-smoking vaccine
10 September 2013
Russian scientists are currently working on the first ever vaccine which could help quit smoking; it may be available in pharmacies in as early as five years. Dmitry Ovchinnikov, Deputy Director General of the company developing the drug, Selecta RUS confirmed: “We’re currently going through the second phase of clinical trials.”
Vaccination against the plague using a Russian drug is currently being carried out in Mongolia
24 July 2024
24 July 2024
Russia will conduct an experiment to block the supply of low-quality products to hospitals
23 July 2024
With seventh person seemingly cured of HIV, signs of hope for a broader cure
23 July 2024